L. Perrone

453 total citations
18 papers, 384 citations indexed

About

L. Perrone is a scholar working on Reproductive Medicine, Surgery and Molecular Biology. According to data from OpenAlex, L. Perrone has authored 18 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in L. Perrone's work include Ovarian cancer diagnosis and treatment (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). L. Perrone is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Glycosylation and Glycoproteins Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). L. Perrone collaborates with scholars based in Italy and United States. L. Perrone's co-authors include Giovanni Scambia, G. Baiocchi, Stefano Iacobelli, Pierluigi Benedetti Panici, Stefano Mancuso, S Mancuso, Salvatore Mancuso, Stefano Greggi, Federica Battaglia and P. Benedetti Panici and has published in prestigious journals such as Cancer, American Journal of Obstetrics and Gynecology and British Journal of Cancer.

In The Last Decade

L. Perrone

18 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Perrone Italy	11	113	107	101	91	73	18	384
Harrison Gallagher United States	12	130 1.2×	94 0.9×	77 0.8×	85 0.9×	58 0.8×	20	404
U Hasholzner Germany	11	182 1.6×	168 1.6×	113 1.1×	80 0.9×	46 0.6×	22	511
Juhani Vartiainen Finland	11	78 0.7×	93 0.9×	42 0.4×	59 0.6×	31 0.4×	15	343
Susan P. Hubbard United States	9	155 1.4×	106 1.0×	59 0.6×	258 2.8×	144 2.0×	9	572
May M.Y. Yu Hong Kong	10	61 0.5×	135 1.3×	176 1.7×	27 0.3×	76 1.0×	12	391
Li Xiao China	11	47 0.4×	108 1.0×	48 0.5×	77 0.8×	67 0.9×	19	351
Alessia Piermattei Italy	15	128 1.1×	115 1.1×	121 1.2×	183 2.0×	72 1.0×	49	535
Pia Asschenfeldt Denmark	10	121 1.1×	100 0.9×	74 0.7×	80 0.9×	26 0.4×	15	415
Mei‐Yung Yu Hong Kong	10	34 0.3×	131 1.2×	131 1.3×	123 1.4×	145 2.0×	16	498
H. Egger Germany	10	163 1.4×	40 0.4×	93 0.9×	76 0.8×	16 0.2×	34	406

Countries citing papers authored by L. Perrone

Since Specialization

Citations

This map shows the geographic impact of L. Perrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Perrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Perrone more than expected).

Fields of papers citing papers by L. Perrone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Perrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Perrone. The network helps show where L. Perrone may publish in the future.

Co-authorship network of co-authors of L. Perrone

This figure shows the co-authorship network connecting the top 25 collaborators of L. Perrone. A scholar is included among the top collaborators of L. Perrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Perrone. L. Perrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Manuelli, Matteo, L. De Luca, Giuseppe Iaria, et al.. (2010). Conversion to Rapamycin Immunosuppression for Malignancy After Kidney Transplantation. Transplantation Proceedings. 42(4). 1314–1316. 35 indexed citations

Iaria, Giuseppe, F Pisani, L. De Luca, et al.. (2010). Prospective Study of Switch From Cyclosporine to Tacrolimus for Fibroadenomas of the Breast in Kidney Transplantation. Transplantation Proceedings. 42(4). 1169–1170. 7 indexed citations

Perrone, L., et al.. (2003). Post-processing of digital images.. PubMed. 28(1). 95–101. 5 indexed citations

Panici, Pierluigi Benedetti, Giovanni Scambia, L. Perrone, et al.. (1993). Oral condyloma lesions in patients with extensive genital human papillomavirus infection. International Journal of Gynecology & Obstetrics. 41(1). 112–112. 1 indexed citations

Panici, Pierluigi Benedetti, Giovanni Scambia, L. Perrone, et al.. (1992). Oral condyloma lesions in patients with extensive genital human papillomavirus infection. American Journal of Obstetrics and Gynecology. 167(2). 451–458. 23 indexed citations

Scambia, Giovanni, Pierluigi Benedetti Panici, Stefano Iacobelli, et al.. (1990). Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies. Cancer. 65(6). 1325–1328. 8 indexed citations

Scambia, Giovanni, et al.. (1990). Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies. British Journal of Cancer. 62(1). 147–151. 6 indexed citations

Scambia, Giovanni, P. Benedetti Panici, Stefano Greggi, et al.. (1990). Phase II study with an LH-RH analog in advanced ovarian cancer. 5–7. 3 indexed citations

Panici, Pierluigi Benedetti, Giovanni Scambia, G. Baiocchi, et al.. (1989). Multiple Serum Markers in Patients with Endometrial Cancer. Gynecologic and Obstetric Investigation. 27(4). 208–212. 18 indexed citations

10.

Panici, P. Benedetti, Giovanni Scambia, Stefano Greggi, et al.. (1989). Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-look. Cancer Treatment Reviews. 16. 123–127. 4 indexed citations

11.

Battaglia, Federica, Giovanni Scambia, Pierluigi Benedetti Panici, et al.. (1989). Epidermal Growth Factor Receptor Expression in Gynecological Malignancies. Gynecologic and Obstetric Investigation. 27(1). 42–44. 51 indexed citations

12.

Scambia, Giovanni, et al.. (1989). Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma.. PubMed. 74(3 Pt 1). 393–7. 35 indexed citations

13.

Scambia, Giovanni, Pierluigi Benedetti Panici, G. Baiocchi, et al.. (1988). Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.. PubMed. 8(4). 761–4. 33 indexed citations

14.

Iacobelli, Stefano, Giovanni Scambia, Clara Natoli, et al.. (1988). Recombinant human leukocyte interferon‐α 2b stimulates the synthesis and release of a 90k tumor‐associated antigen in human breast cancer cells. International Journal of Cancer. 42(2). 182–184. 32 indexed citations

15.

Scambia, Giovanni, Pierluigi Benedetti Panici, G. Baiocchi, et al.. (1988). CA 15-3 Serum Levels in Ovarian Cancer. Oncology. 45(3). 263–267. 18 indexed citations

16.

Scambia, Giovanni, Pierluigi Benedetti Panici, G. Baiocchi, et al.. (1988). Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. Journal of Cancer Research and Clinical Oncology. 114(3). 306–308. 50 indexed citations

17.

Scambia, Giovanni, P. Benedetti Panici, G. Baiocchi, et al.. (1988). CA 15-3 as a tumor marker in gynecological malignancies. Gynecologic Oncology. 30(2). 265–273. 36 indexed citations

18.

Scambia, Giovanni, G. Baiocchi, L. Perrone, et al.. (1988). Growth inhibitory effect of LH-RH analogs on human breast cancer cells.. PubMed. 8(1). 187–90. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact